Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 214
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07330245 DAHLIA — Achievement of LLDAS5 in Patients With Systemic Lupus Erythema… |
Anifrolumab | Lupus | À vérifier | RECRUITING | En attente / non publié | AstraZeneca | Italy · AOU Ospedali Riuniti di Ancona - Presidio Tor… | 2025-12-31 → 2028-09-30 | Ouvrir |
| NCT07720310 Anti-CD19 CAR-T Cell Therapy for Patients With Refractory Systemic Lupu… |
CAR T cells chimeric antigen rece… | Lupus | À vérifier | ENROLLING_BY_INVITATION | En attente / non publié | N.N. Alexandrov National Cancer C… | Belarus · NN Alexandrov National Cancer Centre of Bel… | 2026-03-09 → 2030-06 | Ouvrir |
| NCT07719322 Non Invasive Assessment of Subclinical Atherosclerosis and Cardiovascul… |
Non Invasive Assessment of Subcli… | Lupus | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Assiut University | Egypt · Assuit university hospitals, Asyut, Egypt | 2026-07 → 2029-07 | Ouvrir |
| NCT07719140 Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonizati… |
High-dose prednisone | Lupus | Phase 4 | RECRUITING | En attente / non publié | Peking Union Medical College Hosp… | China · Beijing Children's Hospital, Capital Medical … | 2026-07 → 2029-03 | Ouvrir |
| NCT06799520 A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacodynamics,… |
VIS171 | Lupus | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | Otsuka Pharmaceutical Development… | Bulgaria, Moldova, Romania, Spain · Visterra Investig… | 2025-03-17 → 2027-02-19 | Ouvrir |
| NCT07430306 SUNFLOWER — A Study to Evaluate the Treatment Outcomes of Subcutaneous … |
Anifrolumab | Lupus | Phase 3 | RECRUITING | En attente / non publié | AstraZeneca | United States, Canada, France, Germany, Italy, Mexico… | 2026-04-13 → 2029-01-26 | Ouvrir |
| NCT07721324 SLE — Effect of Melatonin Administration on Systemic Lupus Erythematosu… |
Melatonin | Lupus | Phase 2/3 | NOT_YET_RECRUITING | En attente / non publié | Nishtar Medical University | Egypt · Department of Rheumatology Ain Shams Universi… | 2026-07-21 → 2026-11-21 | Ouvrir |
| NCT07721857 Neutrophil Extracellular Traps and Lupus Nephritis |
Neutrophil Extracellular Traps an… | Lupus | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Assiut University | Non communiqué | 2026-09-01 → 2028-10-31 | Ouvrir |
| NCT07721363 OBLUMEN — Obinutuzumab for Systemic Lupus Erythematosus Pure Membranous… |
Obinutuzumab | Lupus | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | M.D. Anderson Cancer Center | France · Sorbonne University - Nephrology Départment … | 2026-09-02 → 2029-09-02 | Ouvrir |
| NCT05798117 An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics o… |
YTB323 | Lupus | Phase 1/2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Novartis Pharmaceuticals | Australia, France, Germany, Spain, Switzerland · Nova… | 2023-02-28 → 2026-09-24 | Ouvrir |
| NCT06217107 Wellness & Workforce Solution for Lupus/Lupus Nephritis |
Wellness & Workforce Solution for… | Lupus | Non applicable | RECRUITING | En attente / non publié | Morehouse School of Medicine | United States · Morehouse School of Medicine, Atlanta… | 2024-09-14 → 2026-12-31 | Ouvrir |
| NCT07089121 Descartes-08 for Children, Adolescents, and Young Adults With Autoimmun… |
Descartes-08 | Lupus | Phase 1/2 | RECRUITING | En attente / non publié | Cartesian Therapeutics | United States · Cincinnati Children's Hospital Medica… | 2026-01-14 → 2028-12 | Ouvrir |
| NCT02472795 Clinical Study to Investigate the Biological Activity, Safety, Tolerabi… |
Cenerimod | Lupus | Phase 1/2 | COMPLETED | En attente / non publié | Viatris Innovation GmbH | United States, Belarus, Bulgaria, Georgia, Russia, Uk… | 2015-06-01 → 2017-02-28 | Ouvrir |
| NCT06947460 CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH |
CD19-BCMA CAR-T cells infusion | Lupus | Phase 1/2 | RECRUITING | En attente / non publié | Beijing GoBroad Hospital | China · 北京高博医院, Beijing, China | 2025-04-18 → 2026-07-31 | Ouvrir |
| NCT06032923 Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Bo… |
Double-blind Placebo Controlled S… | Lupus | Phase 1/2 | RECRUITING | En attente / non publié | National Heart, Lung, and Blood I… | United States · National Institutes of Health Clinica… | 2024-03-13 → 2028-08-01 | Ouvrir |
| NCT07564596 A Phase 1b/2a Study of Budoprutug in Systemic Lupus Erythematosus (SLE) |
Budoprutug | Lupus | Phase 1/2 | RECRUITING | En attente / non publié | Climb Bio, Inc. | China · Mianyang Central Hospital, Mianyang, China | … | 2026-06-30 → 2027-09 | Ouvrir |
| NCT05835310 BLOSSOM — An Efficacy and Safety Study of Intravenous Anifrolumab to Tr… |
Anifrolumab | Lupus | Phase 3 | RECRUITING | En attente / non publié | AstraZeneca | United States, Argentina, Brazil, Canada, China, Colo… | 2024-03-14 → 2030-01-09 | Ouvrir |
| NCT06897930 A Study to Investigate the Safety, Tolerability, and Efficacy of AZD012… |
AZD0120 | Lupus | Phase 1/2 | RECRUITING | En attente / non publié | Tongji Hospital | United States, Australia, Canada, United Kingdom · Re… | 2025-04-21 → 2029-05-01 | Ouvrir |
| NCT05531565 AMETHYST — A 2-Part Study to Learn Whether Litifilimab (BIIB059) Inject… |
Litifilimab | Lupus | Phase 2/3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Biogen | United States, Argentina, Belgium, Brazil, Bulgaria, … | 2022-09-13 → 2027-12-14 | Ouvrir |
| NCT04833465 Development of a Therapeutic Endpoint in Pediatric Rheumatologic Condit… |
Development of a Therapeutic Endp… | Lupus | À vérifier | RECRUITING | En attente / non publié | Children's National Research Inst… | United States · Children's National Health System, Wa… | 2021-07-16 → 2028-12 | Ouvrir |
| NCT05624749 Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy … |
Ianalumab | Lupus | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Novartis Pharmaceuticals | United States, Argentina, Australia, Chile, Colombia,… | 2023-04-21 → 2029-04-09 | Ouvrir |
| NCT05639114 Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-… |
Ianalumab | Lupus | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Novartis Pharmaceuticals | United States, Argentina, Brazil, Bulgaria, Canada, C… | 2023-03-02 → 2029-03-23 | Ouvrir |
| NCT07598396 SOLUNA — A Study to Evaluate Mosunetuzumab in Participants With Systemi… |
Mosunetuzumab | Lupus | Phase 2 | RECRUITING | En attente / non publié | Hoffmann-La Roche | Brazil, Colombia, Italy, Mexico, South Africa · Admin… | 2026-05-25 → 2028-08-31 | Ouvrir |
| NCT04877691 Tulip SC — Subcutaneous Anifrolumab in Adult Patients With Systemic Lup… |
Medi-546 | Lupus | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | AstraZeneca | United States, Argentina, Bulgaria, Chile, Colombia, … | 2021-06-08 → 2026-11-06 | Ouvrir |
| NCT07729995 BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune Disea… |
LMY-922 | Lupus | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Luminary Therapeutics | United States · Boston Children's Hospital, Boston, U… | 2026-10 → 2030-03 | Ouvrir |